Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Meningioma × Observation × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Multiple Myeloma 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Retinoblastoma 1 Recurrence 1 Precancerous Conditions 1 Pancreatic Neoplasms 1 Osteoporosis 1 Obesity 1 Neoplasms 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1

Interventions

Hydroxyurea 6 Everolimus 6 lutetium Lu 177 dotatate 5 Bevacizumab 5 Magnetic Resonance Spectroscopy 4 Sunitinib 3 pembrolizumab 2 gallium Ga 68 dotatate 2 arginyllysine 2 aldesleukin 2 Whole Body Imaging 2 Specimen Handling 2 Octreotide 2 Nivolumab 2 Imatinib Mesylate 2 Cyclophosphamide 2 Amino Acids 2 90Y-octreotide, DOTA-Tyr(3)- 2 vistusertib 1 vatalanib 1 tozuleristide 1 sargramostim 1 regorafenib 1 pasireotide 1 olaparib 1 neratinib 1 fludarabine phosphate 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡